Epigenetic Modulation of the Tumor Immune Microenvironment to Potentiate Immune Checkpoint Blockade Therapy

Epigenetic Modulation of the Tumor Immune Microenvironment to Potentiate Immune Checkpoint Blockade Therapy

Response rates to immune checkpoint blockade (ICB) in KRAS-mutant lung adenocarcinoma remain poor. In this issue of , Li and colleagues report an CRISPR screen of epigenetic regulators of the tumor immune microenvironment that uncovers as a tumor-intrinsic suppressor of ICB through suppression of GM...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer discovery 2020-02, Vol.10 (2), p.179-181
Hauptverfasser: Menzel, Johannes, Black, Joshua C
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 181
container_issue 2
container_start_page 179
container_title Cancer discovery
container_volume 10
creator Menzel, Johannes
Black, Joshua C
description Response rates to immune checkpoint blockade (ICB) in KRAS-mutant lung adenocarcinoma remain poor. In this issue of , Li and colleagues report an CRISPR screen of epigenetic regulators of the tumor immune microenvironment that uncovers as a tumor-intrinsic suppressor of ICB through suppression of GM-CSF expression. .
doi_str_mv 10.1158/2159-8290.CD-19-1349
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2352052431</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2352052431</sourcerecordid><originalsourceid>FETCH-LOGICAL-c409t-cdf1d464d82f237c939ec0576daa7c3349d02041bd8e6155a9f83bb518ca2c163</originalsourceid><addsrcrecordid>eNo9kE1PwzAMhiMEYtPYP0CoRy4d-WybI3QDJm2CwzhHWeKysLYpbYq0f08nxnyxZb9-LT8I3RI8I0RkD5QIGWdU4lk-j4mMCePyAo3P7ctznfIRmnbdFx6CSy5weo1GjGLKk4yM0X7RuE-oITgTrb3tSx2cryNfRGEH0aavfBstq6qvIVo703qof1zr6wrqEAUfvfswVE4H-FflOzD7xrth_lR6s9d2sNlBq5vDDboqdNnB9JQn6ON5sclf49XbyzJ_XMWGYxliYwtiecJtRgvKUiOZBINFmlitU8OGTy2mmJOtzSAhQmhZZGy7FSQzmhqSsAm6__NtWv_dQxdU5ToDZalr8H2nKBMUC8oZGaT8Tzq81nUtFKppXaXbgyJYHUmrI0Z1RKryuSJSHUkPa3enC_22Ante-ufKfgExinpt</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2352052431</pqid></control><display><type>article</type><title>Epigenetic Modulation of the Tumor Immune Microenvironment to Potentiate Immune Checkpoint Blockade Therapy</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>American Association for Cancer Research</source><creator>Menzel, Johannes ; Black, Joshua C</creator><creatorcontrib>Menzel, Johannes ; Black, Joshua C</creatorcontrib><description>Response rates to immune checkpoint blockade (ICB) in KRAS-mutant lung adenocarcinoma remain poor. In this issue of , Li and colleagues report an CRISPR screen of epigenetic regulators of the tumor immune microenvironment that uncovers as a tumor-intrinsic suppressor of ICB through suppression of GM-CSF expression. .</description><identifier>ISSN: 2159-8274</identifier><identifier>EISSN: 2159-8290</identifier><identifier>DOI: 10.1158/2159-8290.CD-19-1349</identifier><identifier>PMID: 32024681</identifier><language>eng</language><publisher>United States</publisher><ispartof>Cancer discovery, 2020-02, Vol.10 (2), p.179-181</ispartof><rights>2020 American Association for Cancer Research.</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c409t-cdf1d464d82f237c939ec0576daa7c3349d02041bd8e6155a9f83bb518ca2c163</citedby><cites>FETCH-LOGICAL-c409t-cdf1d464d82f237c939ec0576daa7c3349d02041bd8e6155a9f83bb518ca2c163</cites><orcidid>0000-0002-8675-6612</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,3356,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32024681$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Menzel, Johannes</creatorcontrib><creatorcontrib>Black, Joshua C</creatorcontrib><title>Epigenetic Modulation of the Tumor Immune Microenvironment to Potentiate Immune Checkpoint Blockade Therapy</title><title>Cancer discovery</title><addtitle>Cancer Discov</addtitle><description>Response rates to immune checkpoint blockade (ICB) in KRAS-mutant lung adenocarcinoma remain poor. In this issue of , Li and colleagues report an CRISPR screen of epigenetic regulators of the tumor immune microenvironment that uncovers as a tumor-intrinsic suppressor of ICB through suppression of GM-CSF expression. .</description><issn>2159-8274</issn><issn>2159-8290</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNo9kE1PwzAMhiMEYtPYP0CoRy4d-WybI3QDJm2CwzhHWeKysLYpbYq0f08nxnyxZb9-LT8I3RI8I0RkD5QIGWdU4lk-j4mMCePyAo3P7ctznfIRmnbdFx6CSy5weo1GjGLKk4yM0X7RuE-oITgTrb3tSx2cryNfRGEH0aavfBstq6qvIVo703qof1zr6wrqEAUfvfswVE4H-FflOzD7xrth_lR6s9d2sNlBq5vDDboqdNnB9JQn6ON5sclf49XbyzJ_XMWGYxliYwtiecJtRgvKUiOZBINFmlitU8OGTy2mmJOtzSAhQmhZZGy7FSQzmhqSsAm6__NtWv_dQxdU5ToDZalr8H2nKBMUC8oZGaT8Tzq81nUtFKppXaXbgyJYHUmrI0Z1RKryuSJSHUkPa3enC_22Ante-ufKfgExinpt</recordid><startdate>202002</startdate><enddate>202002</enddate><creator>Menzel, Johannes</creator><creator>Black, Joshua C</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-8675-6612</orcidid></search><sort><creationdate>202002</creationdate><title>Epigenetic Modulation of the Tumor Immune Microenvironment to Potentiate Immune Checkpoint Blockade Therapy</title><author>Menzel, Johannes ; Black, Joshua C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c409t-cdf1d464d82f237c939ec0576daa7c3349d02041bd8e6155a9f83bb518ca2c163</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Menzel, Johannes</creatorcontrib><creatorcontrib>Black, Joshua C</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer discovery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Menzel, Johannes</au><au>Black, Joshua C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Epigenetic Modulation of the Tumor Immune Microenvironment to Potentiate Immune Checkpoint Blockade Therapy</atitle><jtitle>Cancer discovery</jtitle><addtitle>Cancer Discov</addtitle><date>2020-02</date><risdate>2020</risdate><volume>10</volume><issue>2</issue><spage>179</spage><epage>181</epage><pages>179-181</pages><issn>2159-8274</issn><eissn>2159-8290</eissn><abstract>Response rates to immune checkpoint blockade (ICB) in KRAS-mutant lung adenocarcinoma remain poor. In this issue of , Li and colleagues report an CRISPR screen of epigenetic regulators of the tumor immune microenvironment that uncovers as a tumor-intrinsic suppressor of ICB through suppression of GM-CSF expression. .</abstract><cop>United States</cop><pmid>32024681</pmid><doi>10.1158/2159-8290.CD-19-1349</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-8675-6612</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 2159-8274
ispartof Cancer discovery, 2020-02, Vol.10 (2), p.179-181
issn 2159-8274
2159-8290
language eng
recordid cdi_proquest_miscellaneous_2352052431
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; American Association for Cancer Research
title Epigenetic Modulation of the Tumor Immune Microenvironment to Potentiate Immune Checkpoint Blockade Therapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T19%3A50%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Epigenetic%20Modulation%20of%20the%20Tumor%20Immune%20Microenvironment%20to%20Potentiate%20Immune%20Checkpoint%20Blockade%20Therapy&rft.jtitle=Cancer%20discovery&rft.au=Menzel,%20Johannes&rft.date=2020-02&rft.volume=10&rft.issue=2&rft.spage=179&rft.epage=181&rft.pages=179-181&rft.issn=2159-8274&rft.eissn=2159-8290&rft_id=info:doi/10.1158/2159-8290.CD-19-1349&rft_dat=%3Cproquest_cross%3E2352052431%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2352052431&rft_id=info:pmid/32024681&rfr_iscdi=true